Medical Disclaimer
  • For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
  • Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
  • Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
The clinical content and references are curated and reviewed by myself; however, AI was used to assist in organizing, paraphrasing, and formatting the information presented.
Quick Reference
  • Primary Use: Detection of myocardial infarction and reinfarction; largely replaced by troponin
  • Normal Range: 3-5% of total CK; absolute values typically <5-25 ng/mL (assay-dependent)
  • Timing: Rises 4-6 hours post-MI, peaks at 12-24 hours, returns to baseline in 48-72 hours
  • Relative Index: CK-MB/Total CK ratio; <3% suggests skeletal muscle, >5% suggests cardiac source
  • Current Role: Useful for detecting reinfarction due to short half-life; troponin preferred for initial MI diagnosis
  • Sample Type: Serum or plasma (venous blood)

Test Description

What is Creatine Kinase (CK)?

Creatine kinase (CK) is an enzyme found in high concentrations in tissues with high energy demands:

  • Cardiac muscle
  • Skeletal muscle
  • Brain

CK Isoenzymes

CK exists in three isoenzyme forms, each primarily found in different tissues:

  • CK-MM: Skeletal muscle (most abundant form in body)
  • CK-MB: Cardiac muscle (the "MB" stands for muscle-brain hybrid)
  • CK-BB: Brain tissue

CK-MB in Modern Practice

CK-MB was historically the primary biomarker for acute myocardial infarction (AMI). While it has largely been replaced by cardiac troponin due to troponin's superior sensitivity and specificity, CK-MB retains clinical utility in specific scenarios, particularly for detecting reinfarction.

Why CK-MB Still Matters: CK-MB returns to baseline within 48-72 hours after MI, whereas troponin remains elevated for 7-14 days. This makes CK-MB useful for detecting reinfarction during the period when troponin is still elevated from the initial event.

CK-MB Relative Index

The CK-MB relative index is calculated as (CK-MB ÷ Total CK) × 100. This ratio helps differentiate cardiac vs skeletal muscle sources of CK elevation:

  • Relative Index <3%: Suggests skeletal muscle source
  • Relative Index >5%: Suggests cardiac muscle source
  • Relative Index 3-5%: Indeterminate; consider clinical context
Normal Reference Ranges

Important Note: Reference ranges vary significantly between laboratories and assay types. Always use institution-specific values.

Swipe to see more
MeasurementNormal RangeElevated/Diagnostic
CK-MB (absolute)< 5-25 ng/mLTypically 2× upper limit of normal
CK-MB (% of total CK)3-5% of total CK15-30% post-MI
CK-MB Relative Index< 3%> 5% suggests cardiac origin
Diagnosis Requires Serial Measurements: The most common diagnostic criterion involves 2 serial elevations above the diagnostic cutoff level or a single result more than twice the upper limit of normal, combined with clinical and ECG evidence.
Timing and Kinetics
Swipe to see more
ParameterCK-MB Timeline
Initial Rise4-6 hours post-myocardial injury
Peak Elevation12-24 hours
Return to Baseline48-72 hours (36-48 hours in some sources)

Clinical Implication of Short Half-Life:

Because CK-MB normalizes within 2-3 days, it can be used to detect reinfarction in patients who present with recurrent chest pain more than 18-24 hours after an initial MI, when troponin levels are still elevated from the first event.

Serial Testing: Measure at presentation and at 6-12 hour intervals. A rising pattern (especially >50% increase) strongly suggests acute MI.
Clinical Significance

Cardiac Causes of Elevation:

  • Acute myocardial infarction (STEMI, NSTEMI)
  • Myocarditis or pericarditis
  • Cardiac trauma or contusion
  • Cardiac surgery or procedures (PCI, ablation, cardioversion)
  • Defibrillation or electrical cardioversion
  • Severe heart failure with cardiac myocyte injury

Non-Cardiac Causes of Elevation:

  • Skeletal Muscle Injury: CK-MB is present in small amounts in skeletal muscle; significant rhabdomyolysis can elevate CK-MB
  • Renal Failure: Decreased clearance can elevate levels
  • Hypothyroidism: Generalized enzyme elevations
  • Pulmonary Embolism: Right heart strain
  • Strenuous Exercise: Especially in untrained individuals
Lower Specificity Than Troponin: CK-MB is less specific for cardiac injury than troponin. Many non-cardiac conditions can cause elevation, and troponin is now the gold standard for AMI diagnosis.
Current Role in Clinical Practice

2025 ACC/AHA Guidelines:

The 2025 ACC/AHA Guidelines for ACS recommend high-sensitivity cardiac troponin (hs-cTn) assays as the preferred biomarker for AMI diagnosis. CK-MB and myoglobin are not recommended for routine ACS diagnosis.

When CK-MB Is Still Useful:

  • Detecting Reinfarction: After 18-24 hours from initial MI, CK-MB may normalize while troponin remains elevated. A new rise in CK-MB can indicate reinfarction.
  • Estimating Infarct Size: Peak CK-MB levels correlate with infarct size (though cardiac MRI is more accurate)
  • Post-PCI Myocardial Injury: Some institutions use CK-MB to assess periprocedural MI
  • Resource-Limited Settings: Where high-sensitivity troponin assays are unavailable
Clinical Pearl: If troponin is available, use it. CK-MB should not be the primary test for diagnosing initial AMI. Reserve CK-MB for special scenarios like suspected reinfarction.
Interfering Factors & Limitations
  • Skeletal Muscle Injury: CK-MB comprises ~1-3% of total CK in skeletal muscle; extensive rhabdomyolysis can cause false elevation
  • Renal Failure: Reduced clearance can elevate CK-MB
  • Hemolysis: Can interfere with some assays
  • Chronic Myopathies: Muscular dystrophy, polymyositis can chronically elevate CK-MB
  • Macro-CK: Rare condition where CK binds to immunoglobulins, causing persistent elevation without clinical significance
Use the Relative Index: Always calculate the CK-MB relative index (CK-MB/Total CK) to help differentiate cardiac from skeletal muscle sources. A ratio >5% favors cardiac origin.
Clinical Pearls
Troponin Is Superior: For initial AMI diagnosis, cardiac troponin (especially high-sensitivity troponin) is more sensitive and specific than CK-MB. CK-MB should not be the primary biomarker if troponin is available.
Reinfarction Detection: CK-MB's primary remaining role is detecting reinfarction during the 2-14 day window when troponin is still elevated from the initial MI. A new rise in CK-MB with recurrent symptoms suggests reinfarction.
Don't Rely on Single Value: Serial measurements (0, 6, 12 hours) with a rising pattern are needed for diagnosis. A single elevated CK-MB is insufficient to diagnose MI.
Calculate the Relative Index: Always look at CK-MB as a percentage of total CK. If CK-MB is elevated but the relative index is <3%, suspect skeletal muscle injury.
Short Half-Life = Advantage: The rapid return to baseline (48-72 hours) is CK-MB's advantage over troponin for specific situations. Use this property to detect reinfarction or estimate timing of MI.
Strenuous Exercise Can Elevate: Marathon runners and intense exercisers can have transiently elevated CK-MB without cardiac injury. Always correlate with clinical context.
References
  1. Kratz, A., Ferraro, M., Sluss, P. M., & Lewandrowski, K. B. (2004). Laboratory reference values. NEJM, 351, 1548-1564.
  2. Lee, M. (Ed.). (2009). Basic skills in interpreting laboratory data. Ashp.
  3. Farinde, A. (2021). Lab values, normal adult. Medscape.
  4. Nickson, C. Critical Care Compendium. Life in the Fast Lane.
  5. Farkas, Josh MD. (2015). EMCrit Project.
Back to Cardiac Panel All Lab Values